Clinical Trials Browser

Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT07063706 2025-07-18

Pharmaceutical Care for Patients Using Capecitabine

Phase NA Completed

176 enrolled

Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03711110 2025-03-21

CARTIER

Phase NA Recruiting

514 enrolled

BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT05355168 2024-12-31

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

Phase 2 Completed

35 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Drug-Related Side Effects and Adverse Reactions

NCT05800054 2023-04-05

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

Phase NA Recruiting

210 enrolled

Gastrointestinal

Esophageal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03246321 2019-10-15

CRC-PIPAC

Phase 2 Completed

20 enrolled

GastrointestinalGynecologic

Appendiceal Neoplasms, Cecal Neoplasms, Intraoperative Complications, Neoplasms, Peritoneal Neoplasms, Postoperative Complications, Colorectal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02447679 2017-02-07

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Phase 2 Completed

40 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Drug-Related Side Effects and Adverse Reactions

NCT00075868 2015-11-17

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Phase 3 Completed

233 enrolled

Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02549911 2015-09-15

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Phase 2 Unknown

40 enrolled

Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00024427 2012-06-28

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Phase 3 Completed

250 enrolled

Gastrointestinal

Pancreatic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01102335 2010-04-13

TACEHBV

Phase 4 Unknown

80 enrolled

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Neoplasms, Drug-Related Side Effects and Adverse Reactions

Clinical Trials

A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects

Pharmaceutical Care for Patients Using Capecitabine

CARTIER

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

CRC-PIPAC

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

TACEHBV